Clinical trials for Bile duct cancer

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Bile duct cancer. For all clinical trials, go to clinical trials search

This list shows clinical trials for Bile duct cancer

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Bile duct cancer
Title Recruitment status Location
Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine Recruiting United Kingdom
A trial looking at whether stereotactic radiotherapy together with chemotherapy is a useful treatment for people with locally advanced bile duct cancer (ABC-07) Recruiting United Kingdom
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer Not recruiting United Kingdom
Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors Not recruiting United Kingdom
Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery Not recruiting United Kingdom
Randomised phase II trial of cediranib (AZD2171) vs. placebo in addition to cisplatin / gemcitabine chemotherapy for patients with advanced biliary tract cancers - ABC-03 Authorised United Kingdom
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer Recruiting United States
Double-blind Randomized Multi-center Trial Regarding the Effects of Solution for Gemcitabine on Frequency and Degree of Vascular Pain in Patients with Cancer Recruiting Japan
Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer Recruiting Korea, Republic of
Feasibility and efficacy of adjuvant gemcitabine chemotherapy after liver transplantation for proximal bile duct cancer Recruiting Germany

Page last reviewed:

Next review due: